ARYx Therapeutics's total assets for Q were $15.23M, a decrease of -20.62% from the previous quarter. ARYX total liabilities were $407.54K for the fiscal quarter, a -87.73% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.